BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 27, 2025
Home » Authors » Shannon Ellis

Articles by Shannon Ellis

China tackles corruption in clinical trials with new rules for hospitals, docs

Nov. 11, 2014
By Shannon Ellis
SHANGHAI – China's hospitals are now required to centralize financial management of clinical trials, set up an enhanced supervision system and strengthen their use of project management tools.
Read More

Johnson & Johnson aims to accelerate innovation in Asia

Nov. 4, 2014
By Shannon Ellis

SHANGHAI – Shanghai is the final leg of Johnson & Johnson's world tour of innovation hot spots – having just cut the ribbon on its fourth J&J Innovation Centre after doing so in London, Boston and California. The Asia Pacific Innovation Center promises to open up J&J resources to the region's best minds in pharmaceuticals, medical devices and health care products. Their aim is clear, to close the gaps in the life sciences ecosystem to accelerate innovation.


Read More

Johnson & Johnson aims to accelerate innovation in Asia

Nov. 4, 2014
By Shannon Ellis
SHANGHAI – Shanghai is the final leg of Johnson & Johnson's world tour of innovation hot spots – having just cut the ribbon on its fourth J&J Innovation Centre after doing so in London, Boston and California.
Read More

China's Betta buys into Xcovery's ALK inhibitor with $20M investment

Oct. 30, 2014
By Shannon Ellis

SHANGHAI – Biotech acquisitions are increasingly becoming a part of the Chinese outbound investment story. This time around, up and comer Betta Pharmacuetical Co., of Hangzhou, Zhejiang, has made a $20 million equity investment in Xcovery Inc., of West Palm Beach, Fla.


Read More

China's cross-border partnering deals set to break record in 2014

Oct. 29, 2014
By Shannon Ellis
SUZHOU, China – The China growth story continues to buoy the life science industry, even in the face of challenging headwinds of change. That was the message from PwC experts who extensively surveyed executives and innovators across device, service, venture capital and pharma, many of whom were in the room for the recent collegial ChinaBio Leadership Retreat in Changshu.
Read More

China's cross-border partnering deals set to break record in 2014

Oct. 29, 2014
By Shannon Ellis
SUZHOU, China – The China growth story continues to buoy the life science industry, even in the face of challenging headwinds of change. That was the message from PwC experts who extensively surveyed executives and innovators across device, service, venture capital and pharma, many of whom were in the room for the recent collegial ChinaBio Leadership Retreat in Changshu.
Read More

China's Betta buys into Xcovery's ALK inhibitor with $20M investment

Oct. 29, 2014
By Shannon Ellis
SHANGHAI – Biotech acquisitions are increasingly becoming a part of the Chinese outbound investment story. This time around, up and comer Zhejiang Betta Pharmacuetical Co. has made a commitment to invest $20 million in equity in Xcovery Inc., of West Palm Beach, Fla.
Read More

Chinese life science leaders, optimistic, working for change

Oct. 22, 2014
By Shannon Ellis
SUZHOU, China – It might be a leadership retreat with golf and sightseeing on the agenda but that only comes after a day of rolling up sleeves and putting heads together to dig into the task of making China a better place for the life sciences industry.
Read More

Chinese life science leaders, optimistic, working for change

Oct. 22, 2014
By Shannon Ellis
SUZHOU, China – It might be a leadership retreat with golf and sightseeing on the agenda but that only comes after a day of rolling up sleeves and putting heads together to dig into the task of making China a better place for the life sciences industry.
Read More

China gives Rotashield vaccine second chance to protect newborns

Oct. 16, 2014
By Shannon Ellis
SHANGHAI – A Chinese vaccine joint venture (JV), Bravovax Co. Ltd., of Wuhan, has taken on the global rights for a rotavirus vaccine to be administered to newborn infants – the first of its kind to protect infants at birth from potentially life threatening diarrhea leading to severe dehydration.
Read More
Previous 1 2 … 42 43 44 45 46 47 48 49 50 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing